Literature DB >> 18612929

Fatigue and blood pressure in primary Sjogren's syndrome.

H Forsblad d'Elia1, E Rehnberg, G Kvist, A Ericsson, Yt Konttinen, K Mannerkorpi.   

Abstract

OBJECTIVE: Primary Sjogren's syndrome (SS) is an autoimmune disease characterized by fatigue. Little is known about the genesis of fatigue. Fatigue is thought to represent a multidimensional concept and it is important to be able to measure it confidently. The aims were to evaluate the reliability and validity of the 20-item Multidimensional Fatigue Inventory (MFI-20) in SS and to search for factors associated with this disabling symptom.
METHODS: Forty-eight women with primary SS completed the MFI-20 questionnaire. The results were compared with age-matched women with fibromyalgia (FM) and healthy controls. Convergent construct validity was assessed by correlations to a Visual Analogue Scale (VAS) for global fatigue by Spearman's correlation (r(s)). Test-retest reliability was analysed by the intraclass correlation coefficient (ICC) in 28 women. Associations between clinical variables and subscales of the MFI-20 were analysed.
RESULTS: The SS women scored significantly higher in all subscales of the MFI-20 compared to controls but similar to FM. The ICCs were satisfactory, ranging from 0.66 for general fatigue to 0.85 for the total score of MFI-20. All subscales correlated significantly to VAS for global fatigue, general fatigue showing the highest correlation (r(s) = 0.70). The estimated number of hours of sleep/day was significantly associated with many of the fatigue dimensions. All five subscales of the MFI-20 were inversely associated with diastolic blood pressure (BP) and two with systolic BP.
CONCLUSIONS: The MFI-20 was found to be a reliable and valid tool for the measurement of fatigue in primary SS. High levels of fatigue were correlated with low BP, suggesting an associated involvement of the autonomic nervous system.

Entities:  

Mesh:

Year:  2008        PMID: 18612929     DOI: 10.1080/03009740801907995

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

1.  Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life.

Authors:  Yousra Ibn Yacoub; Samira Rostom; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-07-24       Impact factor: 2.631

2.  Role and rationale for the use of milnacipran in the management of fibromyalgia.

Authors:  Jay D Kranzler; R Michael Gendreau
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

3.  Patient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.

Authors:  Katherine M Hammitt; April N Naegeli; Remon W M van den Broek; Julie A Birt
Journal:  RMD Open       Date:  2017-09-17

4.  The reliability and validity of The Turkish version of Multidimensional Fatigue Inventory-20 for the evaluation of different dimensions of fatigue in patients with fibromyalgia.

Authors:  Fatma Başoğlu; Julide Öncü; Banu Kuran; Hasan Kerem Alptekin
Journal:  Turk J Phys Med Rehabil       Date:  2020-06-24

5.  Comparison of assessment scores for fatigue between multidimensional fatigue inventory (MFI-K) and modified chalder fatigue scale (mKCFQ).

Authors:  Eun-Jin Lim; Chang-Gue Son
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

6.  Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome.

Authors:  Christina-Maria Flessa; Evangelia Zampeli; Maria-Eleftheria Evangelopoulos; Vasilis Natsis; Iris L A Bodewes; Erika Huijser; Marjan A Versnel; Haralampos M Moutsopoulos; Clio P Mavragani
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

Review 7.  Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions.

Authors:  Samira Tatiyama Miyamoto; Dennis William Lendrem; Wan-Fai Ng; Katie Louise Hackett; Valéria Valim
Journal:  Open Access Rheumatol       Date:  2019-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.